Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
Monoclonal antibodies to prevent respiratory syncytial virus (RSV) disease are under development, but the molecular requirements for cross-subtype neutralization are unclear. Here, the authors show that residue 201 in RSV fusion protein determines subtype specific neutralization for the clinically-r...
Guardado en:
Autores principales: | Daiyin Tian, Michael B. Battles, Syed M. Moin, Man Chen, Kayvon Modjarrad, Azad Kumar, Masaru Kanekiyo, Kevin W. Graepel, Noor M. Taher, Anne L. Hotard, Martin L. Moore, Min Zhao, Zi-Zheng Zheng, Ning-Shao Xia, Jason S. McLellan, Barney S. Graham |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/72a5be0f154c45639beb660fdd77aff7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
por: Iebe Rossey, et al.
Publicado: (2017) -
Correction: Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
por: Iebe Rossey, et al.
Publicado: (2017) -
Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein
por: Michael B. Battles, et al.
Publicado: (2017) -
Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
por: Dirk Roymans, et al.
Publicado: (2017) -
Refining the Balance of Attenuation and Immunogenicity of Respiratory Syncytial Virus by Targeted Codon Deoptimization of Virulence Genes
por: Jia Meng, et al.
Publicado: (2014)